Variables | Total n = 10,333 | Followed n = 8238 | Non-followed n = 2095 | Difference (95% CI) |
---|---|---|---|---|
Age (years) | 39.24 (13.64) | 39.29 (13.25) | 39.02 (15.07) | 0.27 (− 0.38, 0.92) |
Total length of stay in the city (years) | 32.68 (13.47) | 32.88 (13.08) | 31.88 (14.90) | 1.00 (0.30, 1.69) |
BMI (kg/m2) | 26.44 (4.77) | 26.50 (4.67) | 26.20 (5.14) | 0.29 (0.04, 0.54) |
Waist circumference (cm) | 87.23 (12.38) | 87.42 (12.28) | 86.47 (12.75) | 0.95 (0.33, 1.56) |
Wrist circumference (cm) | 16.69 (1.34) | 16.71 (1.34) | 16.64 (1.32) | 0.07 (0.01, 0.13) |
Hip circumference (cm) | 100.18 (9.34) | 100.28 (9.17) | 99.78 (9.98) | 0.50 (0.02, 0.98) |
FPG (mmol/l) | 5.29 (1.59) | 5.27 (1.53) | 5.38 (1.83) | − 0.10 (− 0.19, − 0.01) |
TG (mmol/l) | 1.83 (1.33) | 1.84 (1.34) | 1.80 (1.33) | 0.04 (− 0.02, 0.11) |
TC (mmol/l) | 5.16 (1.15) | 5.17 (1.14) | 5.11 (1.17) | 0.05 (0.01, 0.11) |
HDL-C (mmol/l) | 1.07 (0.28) | 1.07 (0.28) | 1.07 (0.28) | − 0.00 (− 0.01, 0.01) |
eGFR (mL/min/1.73 m2) | 75.70 (10.53) | 75.59 (10.49) | 76.15 (10.70) | − 0.56 (− 1.07, − 0.04) |
SBP (mmHg) | 116.59 (17.40) | 116.49 (17.05) | 116.99 (18.74) | − 0.50 (− 1.33, 0.34) |
DBP (mmHg) | 76.34 (10.65) | 76.39 (10.60) | 76.15 (10.81) | 0.23 (− 0.27, 0.75) |
Heart rate (beats/min) | 79.28 (11.54) | 79.25 (11.50) | 79.40 (11.71) | − 0.15 (− 0.71, 0.40) |
Educationa | ||||
 Level 1 (illiterate) | 2202 (21.3) | 1754 (21.3) | 448 (21.4) | 0.0086 (− 0.0119, 0.0289) |
 Level 2 (< 9 years) | 6000 (58.1) | 4831 (58.6) | 1169 (55.8) | |
 Level 3 (9–12 years) | 1520 (14.7) | 1203 (14.6) | 317 (15.1) | |
 Level 4 (> 12 years) | 611 (5.9) | 450 (5.5) | 161 (7.7) | |
Marital status | ||||
 Single | 1814 (17.6) | 1337 (16.2) | 477 (22.8) | 0.0759 (0.0540, 0.0979) |
 Married | 8149 (78.9) | 6625 (80.4) | 1524 (72.7) | |
 Divorced/widowed | 370 (3.6) | 276 (3.4) | 94 (4.5) | |
FH-CVD in female relatives | 840 (8.1) | 669 (8.1) | 171 (8.2) | − 0.0009 (− 0.0293, 0.0275) |
FH-CVD in male relatives | 843 (8.2) | 657 (8.0) | 186 (8.9) | − 0.019 (− 0.048, 0.009) |
FHD in first-degree relatives | 2801 (27.1) | 2255 (27.4) | 546 (26.1) | 0.0107 (− 0.0066, 0.0280) |
PAL | ||||
 Inactiveb | 6827 (70.5) | 5458 (70.7) | 1369 (69.9) | − 0.0063 (− 0.0239, 0.0114) |
Smoking | ||||
 Never | 7684 (75.6) | 6207 (76.5) | 1477 (72.1) | − 0.0001 (− 0.0305, 0.0304) |
 Past | 702 (6.9) | 567 (7.0) | 135 (6.6) | |
 Current | 1776 (17.5) | 1339 (16.5) | 437 (21.3) | |
Use of blood lipid lowering drugs | 231 (2.2) | 177 (2.1) | 54 (2.6) | − 0.0317 (− 0.0869, 0.0234) |
Use of blood glucose lowering drugs | 320 (3.1) | 234 (2.8) | 86 (4.1) | − 0.0681 (− 0.1173, − 0.0189) |
Use of anti hypertensive drugs | 434 (4.2) | 335 (4.1) | 99 (4.7) | − 0.0265 (− 0.0667, 0.0138) |
Use of aspirin | 933 (9.0) | 717 (8.7) | 216 (10.3) | − 0.0316 (− 0.0599, -0.0034) |
Use of diuretics | 120 (1.2) | 93 (1.1) | 27 (1.3) | − 0.0225 (− 0.0976, 0.0526) |
Prevalence CVD | 324 (3.1) | 219 (2.7) | 105 (5.0) | − 0.1253 (− 0.1768, -0.0737) |